This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This poses a significant challenge for pharmaceuticalmanufacturers, not least because of the technical challenges related to operations, supply chain and the environment. This article explores the potential impact of the proposal and considers how manufacturers can ensure the safety and reliability of their products.
Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceuticalmanufacturing, the addition of AI technologies introduce a paradigm shift. Figure 1 : adapted from Saha, G. Tuijin Jishu/Journal of Propulsion Technology, 44(3), 1384-1392.
In the wake of the Covid-19 pandemic, the Food and Drug Administration continues to struggle with a lack of investigators needed to inspect domestic and foreign pharmaceuticalmanufacturing plants and has not yet developed a plan to keep needed staff, a U.S. government watchdog found.
Quality Documentation and Manufacturing Expertise CDMOs are experienced in generating high-quality documentation required for regulatory submissions and have extensive expertise in drug development and manufacturing. 2023, November 17). 2023, October 12). link] UPM Pharmaceuticals. UPM Pharmaceuticals.
PHARMAP 2023 gathered pharma companies, CMOs and CDMOs, governmental bodies to exchange experience in digital transformation and discuss innovative solutions and business practices. The next edition of the PharmaceuticalManufacturing and Packaging Congress 2024 is going to take place on 22-23, April, in Amsterdam, the Netherlands.
Uncovering new frontiers in microbiology and EM In this Q&A, Laure Pomares Voisin, Quality Director, Catalent Biologics and Tony Cundell Principal Consultant, Microbiological Consulting, LLC discuss some of the key microbiology and environmental monitoring challenges and trends in pharmaceuticalmanufacturing today.
These parks are critical in reducing India’s reliance on China and making the country an attractive location for pharmaceuticalmanufacturing. India’s Economic Ambitions in the Pharmaceutical Industry. 2023, December 6). 2023, October 25). The Rise and Rise of the Pharmaceutical Supply Chain in India.
The global enoxaparin market was valued at US $3,315 million in 2023 and is projected to reach US $5,415 million by 2030, growing at a rate of 7.1 This achievement supports the company’s expansion in new markets and enhances its ability to meet the global demand for enoxaparin. per cent from 2024 to 2030.
Granules India Limited- Walk-In Drive for Quality Control Department On 9th Jan’ 2023. Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Walk-In Drive for Quality Control Department On 9th Jan’ 2023 @ Granules India Limited @ Hyderabad.
Aurobindo Pharma-Walk-In Interviews for Freshers in Production/ Packing On 4th Jan’ 2023. APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Date : 4th Jan’ 2023. Aurobindo Pharma-Walk-In Interviews for Freshers in Production/ Packing On 4th Jan’ 2023.
The CPHI and PMEC India Expo is comprehensively supported by industry associations such as BDMA (Bulk Drug Manufacturing Association), FOPE (Federation of Pharma Entrepreneurs), KDPMA (Karnataka Drugs and PharmaceuticalsManufacturers’ Association), OPPI (Organisation of Pharmaceutical Producers of India), and PharmExcil.
Aurobindo Pharma-Walk-In Interviews for Quality Control On 4th Mar’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!! Walk-In Interviews for Executive/ Sr.
At the beginning of this year, EPR reported on the potential blockbuster pharmaceutical drugs to watch in 2023. The year 2023 also brought much advancement in the Alzheimer’s space for the pharmaceutical industry. Since then, EPR has covered developments for several of the therapies highlighted in the report.
Moreover, pharmaceuticalmanufacturing poses a huge detriment to the state of the planet’s ecosystem. Active pharmaceutical ingredients (APIs) are particularly impact intensive, soaking up a large quantity of resources in terms of heat, energy and water when being produced.
Aurobindo Pharma-Walk-In Interviews for Quality Control/ Production On 7th Jan’ 2023. APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Date : 7th Jan’ 2023. Aurobindo Pharma-Walk-In Interviews for Quality Control/ Production On 7th Jan’ 2023. Job Description.
APL Health Care (Aurobindo )-Walk-In Interviews for IPQA/ Microbiology On 4th Feb’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8
Aurobindo Pharma-Walk-In Interviews for Packing Department On 4th Feb’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 TA/ Executive/ Sr.
Granules India Limited- Walk-In Interviews for Freshers On 7th Jan’ 2023. Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Walk-In Interviews for Freshers On 7th Jan’ 2023 @ Granules India Limited (Gagillapur-Hyderabad). Job Description.
Aurobindo Pharma-Walk-In Interviews for Quality Control On 3rd Feb’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8
Granules India Limited- Walk-In Drive for Freshers in Quality Control/ Production/ Warehouse On 16th Feb’ 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Walk-In Drive for B.Sc / M.Sc/ B.Pharm/ B.Com/ B.A/
In 2023, the company enhanced its Glenview, Illinois facility to meet the rising market need for fluid management systems and virus filtration technologies. These technologies are part of the larger effort to support pharmaceuticalmanufacturers with enhanced process efficiency and product safety.
Aurobindo Pharma-Walk-In Interviews for Production/ Quality Control/ Packing On 5th Mar’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Executive/ Technicians Job Location: Unit-XV, Visakhapatnam, A.P.
Aurobindo Pharma-Walk-In Interviews for Quality Assurance/ Quality Control On 28th Jan’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8
Granules India Limited- Walk-In Interviews for Freshers & Experienced On 5th March 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Granules India Limited- Walk-In Interviews for Freshers & Experienced On 5th March 2023
Aurobindo Pharma-Walk-In Interviews for Quality Assurance/ Quality Control On 7th Jan’ 2023. APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Area of Exposure: RM/ PM/ IP/ FP/ Stability/ GLP & Micro/ Manufacturing & Packing. Date : 7th Jan’ 2023.
Informa Markets in India recently organised the CPHI & PMEC India 2023 at the India Expo Centre in Greater Noida, Delhi-NCR. The post Informa Markets organises CPHI & PMEC India 2023 successfully at India Expo Centre appeared first on Express Pharma.
Based on the new cost estimates, pharmaceuticalmanufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.
Valentine , as a 2023 Rising Star. Karst Awarded WWL: Life Sciences 2023 Global Elite Thought Leader HP&M Director Kurt R. Karst was named by Who’s Who Legal: Life Sciences 2023 as one of only 14 “Global Elite Thought Leaders.” This is an achievement that only around 5% of WWL-listed practitioners were accorded in 2023.
The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceuticalmanufacturing and quality control.
Revised for 2023, the Parenteral Drug Association (PDA) has published an update to its Technical Report No. 43: Identification and Classification of Nonconformities in Moulded and Tubular Glass Containers for PharmaceuticalManufacturing.
Responsible Sourcing Starting in 2022, Lonza established a dedicated Responsible Sourcing Team, followed by membership with the Together for Sustainability (TfS) initiative and collaboration with EcoVadis in 2023. In March 2024, Lonza hosted its first digital Responsible Supplier Event which brought together more than 1,100 participants.
billion and another 200 new jobs is planned for Eli Lilly and Company’s two new pharmaceuticalmanufacturing sites in Boone County, US. Eli Lilly’s investment here is the largest manufacturing investment at a single location in its history. Students will also be able to access a smart manufacturing lab.
Leaders of the whole pharma value chain meet at PharmaceuticalManufacturing and Packaging Congress (PHARMAP) to find new connections and discuss trends of the industry. Mohamed Chalal, New Product Introduction Manufacturing Sr.
Delpharm has acquired the Meppel pharmaceuticalmanufacturing facility in the Netherlands from Astellas. The acquisition will strengthen the CDMO’s position in the Netherlands, where it already owns a manufacturing facility in Bladel and an injectable drug development centre in Leiden. billion in 2024.
This week, I’m rerunning some popular posts while I put the finishing touches on DCI's new 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Click here to see the original post from June 2023. Time for Drug Channels ’ annual update on pricing at the largest pharmaceuticalmanufacturers.
Granules India Limited- Walk-In Interviews for Freshers On 16th Feb’ 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Granules India Limited- Walk-In Interviews for Freshers On 16th Feb’ 2023
Innovations in the process spectroscopy market molecular spectroscopy accounted for the greatest share of the process spectroscopy market between 2023 to 2033″ The analysis found that molecular spectroscopy accounted for the greatest share of the process spectroscopy market between the 2023 to 2033 forecast period.
Novo Nordisk has announced plans to invest over 42 billion Danish kroner (nearly £5 billion) starting in 2023, to expand its manufacturing facilities in Kalundborg, Denmark. According to the pharma company , the financing will add to global capacity: from manufacturing of active pharmaceutical ingredients (API) through to packaging.
The global pharmaceutical industry experienced a 114% rise in company filings mentions of environmental sustainability in Q1 2023 compared with the previous quarter, with the highest share accounted for by Novozymes with 27% year-on-year increase, according to GlobalData’s analysis of over 757 pharmaceutical company filings.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content